Market Snapshot
| Study Period: | 2018 - 2026 |
| Base Year: | 2020 |
| CAGR: | 8.73 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Market Overview
The Canadian respiratory devices market was anticipated to record a CAGR of 8.73%, during the forecast period. The major factors attributing to the growth of the Canadian respiratory devices market are the rise in the number of chronic obstructive pulmonary disease patients (COPD), TB, asthma, and pneumonia cases. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. In Canada, COPD is the fourth most frequent cause of male hospitalization and the sixth most frequent cause of female hospitalization. Roughly 500,000 people over the age of 35 were recently identified with COPD and it is believed that roughly an equal number of middle-aged Canadians may have COPD as well. As per the Asthma.Ca 2019, it was reported that more than 3.8 million people in Canada are currently suffering from asthma, with around 850,000 of them being children under 14. The other factors helping the growth of the respiratory devices market are the increasing technological advancements in the country and the growing funding from the government for the health sector, which may also fuel the market growth during the forecast period.
Scope of the report
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. They may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia.
| By Diagnostic and Monitoring Devices | |
| Spirometers | |
| Sleep Test Devices | |
| Peak Flow Meters | |
| Pulse Oximeters | |
| Capnographs | |
| Other Diagnostic and Monitoring Devices |
| By Therapeutic Device | |
| CPAP Devices | |
| BiPAP Devices | |
| Humidifiers | |
| Nebulizers | |
| Oxygen Concentrators | |
| Ventilators | |
| Inhalers | |
| Other Therapeutic Devices |
| By Disposables | |
| Masks | |
| Breathing Circuit | |
| Other Disposables |
Key Market Trends
Sleep Test Devices Segment is Expected to have the Fastest Growth in the Canadian Respiratory Devices Market
Due to the rising development of portable devices, such as CleveMed's SleepView [home sleep monitor], which incorporates multiple tests (oximetry, location, and cardiovascular and respiratory studies), home sleep monitoring is anticipated to experience exponential growth. In fact, some of the sleep monitoring instruments can be leased, contributing to the growth of the market. These factors are expected to contribute to the growth of the market during the forecast period.
To understand key trends, Download Sample Report
Competitive Landscape
The Canadian respiratory devices market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market and some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions in the country. Some of the companies that are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co. Inc., CooperSurgical, Inc., and Allergan PLC.
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
-
4.2.2 Technological Advancements and Increasing Applications in the Homecare Setting
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Devices
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Diagnostic and Monitoring Devices
-
5.1.1 Spirometers
-
5.1.2 Sleep Test Devices
-
5.1.3 Peak Flow Meters
-
5.1.4 Pulse Oximeters
-
5.1.5 Capnographs
-
5.1.6 Other Diagnostic and Monitoring Devices
-
-
5.2 By Therapeutic Device
-
5.2.1 CPAP Devices
-
5.2.2 BiPAP Devices
-
5.2.3 Humidifiers
-
5.2.4 Nebulizers
-
5.2.5 Oxygen Concentrators
-
5.2.6 Ventilators
-
5.2.7 Inhalers
-
5.2.8 Other Therapeutic Devices
-
-
5.3 By Disposables
-
5.3.1 Masks
-
5.3.2 Breathing Circuit
-
5.3.3 Other Disposables
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Philips Healthcare
-
6.1.2 ResMed Inc.
-
6.1.3 Medtronic PLC
-
6.1.4 Masimo Corporation
-
6.1.5 GE Healthcare
-
6.1.6 Chart Industries Inc.
-
6.1.7 Dragerwerk AG & Co. KGaA
-
6.1.8 Hamilton Medical AG
-
6.1.9 Fisher and Paykel Healthcare Limited
-
6.1.10 Becton, Dickinson and Company
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Canada Respiratory Devices Market market is studied from 2018 - 2026.
What is the growth rate of Canada Respiratory Devices Market?
The Canada Respiratory Devices Market is growing at a CAGR of 8.73% over the next 5 years.
Who are the key players in Canada Respiratory Devices Market?
Philips Healthcare, ResMed Inc., Medtronic plc, Masimo Corporation, GE Healthcare are the major companies operating in Canada Respiratory Devices Market.
